JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200

Watchlist Manager
JiangSu WuZhong Pharmaceutical Development Co Ltd Logo
JiangSu WuZhong Pharmaceutical Development Co Ltd
SSE:600200
Watchlist
Price: 9.59 CNY -2.84% Market Closed
Market Cap: 6.8B CNY
Have any thoughts about
JiangSu WuZhong Pharmaceutical Development Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

192.6
Current
-266.3
Median
13.3
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
192.6
=
Enterprise Value
7B CNY
/
EBITDA
36.2m CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
31.6
2-Years Forward
EV/EBITDA
17.7
3-Years Forward
EV/EBITDA
13.3

See Also

Discover More